indazoles has been researched along with Carcinoma, Lewis Lung in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Gong, Y; Jiang, X; Li, J; Luo, Y; Xie, C; Zeng, Z; Zhang, J; Zhang, N | 1 |
| Buchi, M; D'Amico, L; Kashyap, AS; Läubli, H; Müller, P; Zippelius, A | 1 |
| Anderson, KD; Davis, RB; Gowen, LC; Hashizume, H; Haskell, A; Joho, S; Kamba, T; Kuo, CJ; Mancuso, MR; McDonald, DM; Norberg, SM; O'Brien, SM; Sennino, B; Springer, ML; Tam, BY; Thurston, G | 1 |
| Hu-Lowe, DD; McDonald, DM; Nakahara, T; Norberg, SM; Shalinsky, DR | 1 |
| Brooks, P; Davis, R; Freimark, B; Hu-Lowe, DD; Inai, T; Mancuso, MR; McDonald, DM; Nakahara, T; Norberg, SM; O'Brien, S; Sennino, B; Shalinsky, DR; Yao, VJ | 1 |
5 other study(ies) available for indazoles and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer.
Topics: Animals; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemokine CCL5; Chemokine CXCL10; Chemoradiotherapy; DNA Breaks, Double-Stranded; Female; Fluorescent Antibody Technique; Genes, erbB-1; Humans; Immune System; Immunocompetence; Indazoles; Interferon Regulatory Factor-3; Interferon-beta; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Membrane Proteins; Mice; Mice, Inbred C57BL; Mutation; Nuclear Proteins; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Serine-Threonine Kinases; Radiation Tolerance; Radiation-Sensitizing Agents; Real-Time Polymerase Chain Reaction; TATA Box Binding Protein-Like Proteins; Tumor Stem Cell Assay | 2021 |
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.
Topics: Animals; Antibodies, Monoclonal; Axitinib; Carcinoma, Lewis Lung; Disease Models, Animal; Drug Synergism; Hepatitis A Virus Cellular Receptor 2; Imidazoles; Immunosuppression Therapy; Immunotherapy; Indazoles; Mice; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured; Tumor Necrosis Factor Receptor Superfamily, Member 9; Vascular Endothelial Growth Factor A | 2018 |
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.
Topics: Aging; Animals; Axitinib; Blood Pressure; Capillaries; Carcinoma, Lewis Lung; Glucose Tolerance Test; Heart; Imidazoles; Indazoles; Islets of Langerhans; Kidney; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Pancreatic Neoplasms; Phenotype; Reference Values; Regeneration; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Effect of inhibition of vascular endothelial growth factor signaling on distribution of extravasated antibodies in tumors.
Topics: Adenoma, Islet Cell; Animals; Antibodies, Neoplasm; Axitinib; Cadherins; Carcinoma, Lewis Lung; Fibrin; Imidazoles; Immunoglobulin G; Indazoles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microspheres; Neovascularization, Pathologic; Signal Transduction; Vascular Endothelial Growth Factor A | 2006 |
Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Topics: Actins; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Axitinib; Basement Membrane; Blood Vessels; Carcinoma, Lewis Lung; Collagen Type IV; Endothelium, Vascular; Imidazoles; Indazoles; Insulinoma; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms; Neovascularization, Pathologic; Organic Chemicals; Pericytes; Platelet Endothelial Cell Adhesion Molecule-1; Receptor, Platelet-Derived Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2006 |